2012 Current Cancer Dedicated to bringing the latest news and information on cancer diagnosis, treatment and prevention.

Archive for the ‘Cancer News’ Category

New Target May Be Eyed in Kids’ Brain Cancer

Scientists have identified oncogenes that play a role in a particularly aggressive type of childhood brain tumor. Known as central nervous system primitive neuroectodermal tumors (CNS-PNETs), the discovery of these oncogenes may lead to improved diagnosis and treatment of the deadly condition. “Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle ...

Certain Childhood Cancers More Likely to Recur

Some childhood cancers, particularly Ewing sarcomas and central nervous system tumors, carry the risk of late recurrence, U.S. researchers have found. The study authors analyzed data from 12,795 five-year survivors of the most common pediatric cancers who were enrolled in the Childhood Cancer Survivor Study. The researchers found that the overall cancer recurrence rate was ...

High-Risk Women May Often Avoid Using Tamoxifen

Worries about side effects are a major reason why only 6 percent of American women at high risk for breast cancer are willing to take the drug tamoxifen to prevent the disease, a new study finds. In an effort to inform women about the risks and benefits of tamoxifen, researchers at the University of Michigan ...

Lung Cancer’s Racial Gap Narrowing

Efforts to prevent teens from smoking have helped narrow the racial disparity in lung cancer incidence and death rates among adults in the United States, researchers say. Smoking causes most lung cancer cases in the United States. Lung cancer cases have been consistently higher in blacks than in whites at all ages. Since the 1970s, ...

NCI Awards Cancer Information Service Contact Center

The National Cancer Institute (NCI), part of the National Institutes of Health, announced yesterday the selection of a single organization for a multiple year contract award to operate its Cancer Information Service (CIS) Contact Center. The program will be located at Fred Hutchinson Cancer Research Center in Seattle, Wash., and will serve the United States, ...